Stephen Carey

Track

Insider profile

Currently holds a position at ANI Pharmaceuticals, Inc.

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Corporate Secretary, Vice President, Finance and Chief Financial Officer ANI Pharmaceuticals, Inc. May 6, 2016 -
Stephen Carey's trades of ANI Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
75.56
Quantity 4,000 -2.1%
Value US$302,240
Transaction date
Proposed sale
Price
75.49
Quantity 7,312
Value US$552,017
Transaction date
Sale
Price
86.07
Quantity 50,000 -21.7%
Value US$4,303,500
Transaction date
Proposed sale
Price
86.07
Quantity 50,000
Value US$4,303,590
Transaction date
Proposed sale
Price
55.25
Quantity 7,500
Value US$414,375
Transaction date
Proposed sale
Price
62.00
Quantity 5,000
Value US$310,000
Transaction date
Proposed sale
Price
65.00
Quantity 7,787
Value US$506,155
Transaction date
Proposed sale
Price
60.50
Quantity 17,639
Value US$1,067,160
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-01 2026-08-31
PlS Planned sale
43,845 -6.3%
307.51
US$4,426,668 		43,845 -6.3% 307.51 US$4,426,668
2026-07-30 2026-07-29
PlS Planned sale
70,056 -34.8%
131.85
US$1,138,775 		70,056 -34.8% 131.85 US$1,138,775
2026-07-29 2026-07-29
PrS Proposed sale
85,432
10.91
US$4,105,607 		85,432 10.91 US$4,105,607
2026-07-06 2026-07-02
PlS Planned sale
3,313 -1.8%
86.00
US$284,918 		3,313 -1.8% 86.00 US$284,918
2026-06-30 2026-06-29
PlS Planned sale
2,850 -1.6%
84.12
US$239,742 		2,850 -1.6% 84.12 US$239,742
2026-06-09 2026-06-05
PlS Planned sale
3,312 -1.8%
80.00
US$264,960 		3,312 -1.8% 80.00 US$264,960
2026-06-05 2026-06-05
PrS Proposed sale
11,862
79.20
US$939,470 		11,862 79.20 US$939,470
2026-06-05 2026-06-05
PrS Proposed sale
11,862
79.20
US$939,470 		11,862 79.20 US$939,470
2026-03-05 2026-03-05
S Sale
4,000 -2.1%
75.56
US$302,240 		4,000 -2.1% 75.56 US$302,240
2026-03-05 2026-03-05
S Sale
3,312 -1.7%
75.42
US$249,791 		3,312 -1.7% 75.42 US$249,791
2026-03-05 2026-03-05
PrS Proposed sale
7,312
75.49
US$552,017 		7,312 75.49 US$552,017
2025-08-14 2025-08-12
S Sale
50,000 -21.7%
86.07
US$4,303,500 		50,000 -21.7% 86.07 US$4,303,500
2025-08-12 2025-08-12
PrS Proposed sale
50,000
86.07
US$4,303,590 		50,000 86.07 US$4,303,590
2024-12-18 2024-12-17
S Sale
7,500 -4.6%
55.79
US$418,425 		7,500 -4.6% 55.79 US$418,425
2024-12-17 2024-12-17
PrS Proposed sale
7,500
55.25
US$414,375 		7,500 55.25 US$414,375
2024-06-06 2024-06-04
S Sale
5,000 -3.0%
63.58
US$317,900 		5,000 -3.0% 63.58 US$317,900
2024-06-04 2024-06-04
PrS Proposed sale
5,000
62.00
US$310,000 		5,000 62.00 US$310,000
2024-03-11 2024-03-11
PrS Proposed sale
7,787
65.00
US$506,155 		7,787 65.00 US$506,155
2024-03-11 2024-03-11
S Sale
7,787 -4.2%
65.55
US$510,438 		7,787 -4.2% 65.55 US$510,438
2023-08-16 2023-08-14
S Sale
17,639 -10.2%
61.37
US$1,082,505 		17,639 -10.2% 61.37 US$1,082,505
2023-08-14 2023-08-14
PrS Proposed sale
17,639
60.50
US$1,067,160 		17,639 60.50 US$1,067,160